Search results
Moderna, Inc. (NASDAQ:MRNA) Director Noubar Afeyan Sells 15,000 Shares
ETF DAILY NEWS· 3 days agoFollowing the completion of the transaction, the director now owns 2,011,931 shares in the company, valued at approximately $244,811,764.08. On Wednesday, May 1st, Noubar Afeyan sold 15,000 ...
Jim Cramer: This Industrial Company Is ‘Absolutely Terrific’, Recommends Buying Modine Manufacturing...
Benzinga· 1 day agoOn CNBC's “Mad Money Lightning Round,” Jim Cramer believes in Moderna, Inc. On May 14, Evercore ISI Group analyst Cory Kasimov initiated coverage on Moderna
Novavax, Nvidia, Sweetgreen rise premarket; Moderna, Yelp fall By Investing.com
Investing.com· 6 days agoNovavax, Nvidia, Sweetgreen rise premarket; Moderna, Yelp fall
Moderna Tumbles After The FDA Throws A Curveball On Its Second Product
Investor's Business Daily· 6 days agoModerna stock toppled Friday after the Food and Drug Administration delayed an approval decision on...
While shareholders of Moderna (NASDAQ:MRNA) are in the black over 5 years, those who bought a week...
Simply Wall St. via Yahoo Finance· 3 days agoIf you are thinking of buying or selling Moderna stock, you should check out this free report...
Wealthspire Advisors LLC Has $301,000 Stock Position in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 4 days agoThe institutional investor owned 3,028 shares of the company’s stock after selling 261 shares during the quarter. Wealthspire Advisors LLC’s holdings in Moderna< ...
Moderna’s mRNA dreams meet reality with first post-COVID shot - The Boston Globe
The Boston Globe· 7 days agoModerna’s stock dropped 45 percent last year, making it the worst-performing large biotech in the...
Unveiling Moderna (MRNA)'s Value: Is It Really Priced Right? A C
Guru Focus· 3 days agoDespite these impressive numbers, a deeper look into the company's financials reveals a Loss Per Share of 15.67. This analysis aims to determine whether Moderna's
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Zacks via Yahoo Finance· 3 days agoIt expects to generate around $4 billion in product revenues, driven mainly by the sales of its...
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
Motley Fool via Yahoo Finance· 3 days agoWith those opportunities ahead, DexCom's future looks bright. Investors with a long-term focus can...